XBIOTECH INC (XBIT) Stock Price, Quote, News and Overview
NASDAQ:XBIT - Nasdaq - CA98400H1029 - Common Stock - Currency: USD
XBIT Quote, Performance and Key Statistics
NASDAQ:XBIT (8/20/2025, 8:00:02 PM)
3.22
+0.01 (+0.31%)
The current stock price of XBIT is 3.22 USD. In the past month the price increased by 3.87%. In the past year, price decreased by -51.06%.
XBIT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.75 | 369.44B | ||
| AMGN | AMGEN INC | 13.59 | 159.40B | ||
| GILD | GILEAD SCIENCES INC | 15.34 | 147.69B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.28 | 101.27B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.95 | 63.81B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 59.76B | ||
| ARGX | ARGENX SE - ADR | 71.3 | 40.45B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.7 | 33.48B | ||
| BNTX | BIONTECH SE-ADR | N/A | 26.76B | ||
| INSM | INSMED INC | N/A | 24.56B | ||
| NTRA | NATERA INC | N/A | 21.94B | ||
| BIIB | BIOGEN INC | 8.68 | 20.37B |
Related stock screener links
About XBIT
Company Profile
XBiotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic antibodies. The company is headquartered in Austin, Texas and currently employs 92 full-time employees. The company went IPO on 2015-04-15. The firm's True Human monoclonal antibodies are derived from human donors that mount a natural human immune response. The firm is focused on therapies that block a potent substance, known as interleukin-1 alpha (IL-1a), that mediates a number of pathophysiological processes including tissue breakdown (i.e. synovium, cartilage, bone), paraneoplastic angiogenesis and tumor stroma remodeling, formation of blood clots, malaise, muscle wasting and general inflammation. The company has various candidate products, including Natrunix. The company has a clinical-stage therapeutic for methicillin resistant Staphylococcus aureus (MRSA), and several pre-clinical-stage therapeutics, including an oral delivery antibody therapeutic for colon infection by C. difficile.
Company Info
XBIOTECH INC
5217 Winnebago Lane
Austin TEXAS 78744 US
CEO: John Simard
Employees: 92
Phone: 15123862900
XBIOTECH INC / XBIT FAQ
What is the stock price of XBIOTECH INC today?
The current stock price of XBIT is 3.22 USD. The price increased by 0.31% in the last trading session.
What is the ticker symbol for XBIOTECH INC stock?
The exchange symbol of XBIOTECH INC is XBIT and it is listed on the Nasdaq exchange.
On which exchange is XBIT stock listed?
XBIT stock is listed on the Nasdaq exchange.
What is XBIOTECH INC worth?
XBIOTECH INC (XBIT) has a market capitalization of 98.18M USD. This makes XBIT a Micro Cap stock.
How many employees does XBIOTECH INC have?
XBIOTECH INC (XBIT) currently has 92 employees.
What are the support and resistance levels for XBIOTECH INC (XBIT) stock?
XBIOTECH INC (XBIT) has a support level at 3.21 and a resistance level at 3.22. Check the full technical report for a detailed analysis of XBIT support and resistance levels.
Should I buy XBIOTECH INC (XBIT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of XBIT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of XBIT, evaluating the profitability, health, valuation and growth aspects
- XBIOTECH INC (XBIT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- XBIOTECH INC (XBIT) Sales and EPS estimates to see what analysts future expectations are.
- XBIOTECH INC (XBIT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- XBIOTECH INC (XBIT) Insider and Institutional Ownership to learn about the owners and their transactions.
- XBIOTECH INC (XBIT) Stock Chart to make your own analysis
- XBIOTECH INC (XBIT) Latest news and press-releases to stay up to date.
Does XBIOTECH INC (XBIT) stock pay dividends?
XBIT does not pay a dividend.
When does XBIOTECH INC (XBIT) report earnings?
XBIOTECH INC (XBIT) will report earnings on 2025-11-11.
What is the Price/Earnings (PE) ratio of XBIOTECH INC (XBIT)?
XBIOTECH INC (XBIT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.3).
What is the Short Interest ratio of XBIOTECH INC (XBIT) stock?
The outstanding short interest for XBIOTECH INC (XBIT) is 2.19% of its float. Check the ownership tab for more information on the XBIT short interest.
XBIT Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to XBIT. When comparing the yearly performance of all stocks, XBIT is a bad performer in the overall market: 88.26% of all stocks are doing better.
XBIT Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to XBIT. No worries on liquidiy or solvency for XBIT as it has an excellent financial health rating, but there are worries on the profitability.
XBIT Financial Highlights
Over the last trailing twelve months XBIT reported a non-GAAP Earnings per Share(EPS) of -1.3. The EPS decreased by -28.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -21.67% | ||
| ROE | -22.56% | ||
| Debt/Equity | 0 |
XBIT Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to XBIT. The Buy consensus is the average rating of analysts ratings from 7 analysts.